Lupus Research Alliance harmonised molecular and clinical data from 9+ CROs on a Lifebit federated platform.
Cross-border privacy rules, costly transfers and data from many CROs limited research access. Lifebit's federated TRE underpins the DREAM platform with OMOP-mapped data and tools from spreadsheets to Jupyter. The page reports 100% OMOP coverage, 3 clinical sites onboarded, 100% adherence to US and Canadian governance and 30-90% lower cloud costs.
Lifebit is a federated data and trusted research environment vendor, used by pharma and public health bodies to analyse sensitive genomic and clinical data in place
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Lifebit on its own site — read the original case study on lifebit.ai ↗
Related use cases
- 01Boehringer Ingelheim analysed UK Biobank and Genomics England data in place using Lifebit's federated research environment.
- 02Flatiron Health federated global oncology data analysis across jurisdictions with Lifebit.
- 03Genomics England analysed 2,500+ breast cancer genomes in a Lifebit federated environment.
- 04How Bioventus evolved their commercial strategy with real world data and intelligence
- 05Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 06Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study